OptiBiotix Health (LON:OPTI) Shares Cross Below 50-Day Moving Average – What’s Next?

OptiBiotix Health Plc (LON:OPTI) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 6.03 and traded as low as GBX 5.60. OptiBiotix Health shares last traded at GBX 5.94, with a volume of 466,493 shares trading hands.

OptiBiotix Health Stock Up 3.3%

The firm has a fifty day moving average of GBX 6.03 and a 200-day moving average of GBX 5.95. The stock has a market capitalization of £6.14 million, a price-to-earnings ratio of -1.55 and a beta of 1.82.

OptiBiotix Health (LON:OPTI) last posted its earnings results on Thursday, May 28th. The company reported GBX (3.84) earnings per share for the quarter. OptiBiotix Health had a negative net margin of 333.62% and a negative return on equity of 52.92%. The firm had revenue of GBX 117 million during the quarter.

Insider Activity at OptiBiotix Health

In other OptiBiotix Health news, insider David Blain acquired 158,965 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were purchased at an average cost of GBX 6 per share, with a total value of £9,537.90. 26.79% of the stock is owned by corporate insiders.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.